SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-127240
Filing Date
2023-12-19
Accepted
2023-12-19 13:41:42
Documents
1
Group Members
SANGWOO PARK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2332253d1_sc13da.htm SC 13D/A 44919
  Complete submission text file 0001104659-23-127240.txt   46640
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Subject) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92576 | Film No.: 231496672
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705
Business Address C/O NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705 949-396-6830
NKMAX Co., Ltd. (Filed by) CIK: 0001996481 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D/A